Medicare Enrolled

Dr. Maritoni Malvar, MD

Family Medicine · New Castle, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
178 ENCLAVE DR, New Castle, PA 16105
7246587765
Registered in NPPES since 2006
NPI: 1255309324 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Malvar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Malvar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Malvar

Dr. Maritoni Malvar is a family medicine specialist in New Castle, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Malvar performed 87 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Malvar received a total of $14,272 from 49 pharmaceutical and/or device companies across 692 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Malvar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 87 Medicare services $14,272 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
87
Medicare services
Bottom 11% in PA for family medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
47 $84 $160
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
25 $123 $275
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
15 $49 $115
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,272
Total received (2018-2024)
Avg $2,039/year across 7 years
Top 3% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
692
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,663
2023
$2,858
2022
$2,304
2021
$2,014
2020
$1,171
2019
$1,141
2018
$1,121

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$456
ABBVIE INC.
$450
GlaxoSmithKline, LLC.
$434
Amgen Inc.
$332
Phathom Pharmaceuticals, Inc.
$270
Lilly USA, LLC
$202
Bayer Healthcare Pharmaceuticals Inc.
$188
Novo Nordisk Inc
$187
Boehringer Ingelheim Pharmaceuticals, Inc.
$176
E.R. Squibb & Sons, L.L.C.
$171
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$168
Exact Sciences Corporation
$147
Alkermes, Inc.
$87
Mylan Specialty L.P.
$84
PFIZER INC.
$77
Abbott Laboratories
$45
Sumitomo Pharma America, Inc.
$38
Amphastar Pharmaceuticals, Inc.
$38
Lundbeck LLC
$22
Astellas Pharma US Inc
$22
Novartis Pharmaceuticals Corporation
$21
Paratek Pharmaceuticals, Inc.
$18
Currax Pharmaceuticals LLC
$15
Takeda Pharmaceuticals U.S.A., Inc.
$14
Top 3 companies account for 36.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,953
Amgen Inc.
$1,772
ABBVIE INC.
$1,523
Novo Nordisk Inc
$1,053
GlaxoSmithKline, LLC.
$823
Lilly USA, LLC
$686
Janssen Pharmaceuticals, Inc
$676
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$574
Amarin Pharma Inc.
$541
PFIZER INC.
$462
Boehringer Ingelheim Pharmaceuticals, Inc.
$422
Exact Sciences Corporation
$392
Bayer HealthCare Pharmaceuticals Inc.
$335
Phathom Pharmaceuticals, Inc.
$270
Novartis Pharmaceuticals Corporation
$269
AbbVie Inc.
$266
E.R. Squibb & Sons, L.L.C.
$251
Bayer Healthcare Pharmaceuticals Inc.
$237
Daiichi Sankyo Inc.
$194
Merck Sharp & Dohme Corporation
$173
Kowa Pharmaceuticals America, Inc.
$137
Merck Sharp & Dohme LLC
$135
Eisai Inc.
$122
Abbott Laboratories
$92
Alkermes, Inc.
$87
Mylan Specialty L.P.
$84
Esperion Therapeutics, Inc.
$81
Takeda Pharmaceuticals U.S.A., Inc.
$76
Sumitomo Pharma America, Inc.
$70
Lundbeck LLC
$67
IDORSIA PHARMACEUTICALS US INC
$44
Xeris Pharmaceuticals, Inc.
$41
Amphastar Pharmaceuticals, Inc.
$38
Currax Pharmaceuticals LLC
$31
Circassia Pharmaceuticals Inc
$30
Avanir Pharmaceuticals, Inc.
$29
Phadia US Inc.
$24
Astellas Pharma US Inc
$22
SANOFI-AVENTIS U.S. LLC
$22
Biogen, Inc.
$21
Biohaven Pharmaceutical Holding Company Ltd.
$21
West-Ward Pharmaceuticals
$19
Paratek Pharmaceuticals, Inc.
$18
EISAI INC.
$18
AbbVie, Inc.
$18
Almatica Pharma LLC
$16
Seqirus USA Inc
$13
Horizon Therapeutics plc
$13
Regeneron Healthcare Solutions, Inc.
$12
Top 3 companies account for 36.8% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIRSUPRA · ANORO · AREXVY · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BREO · BREZTRI · CAMZYOS · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · Cologuard Collection Kit · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GEMTESA · GRALISE · GVOKE HYPOPEN · INJECTAFER · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · Kerendia · LEQVIO · Livalo · MOUNJARO · MOVANTIK · Mitigare · NEXLETOL · NIOX VERO · NUEDEXTA · NURTEC ODT · NUZYRA · Nuedexta · ONZETRA XSAIL · Otezla · Ozempic · PAXLOVID · PENNSAID · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYNTHROID · Saxenda · Synthroid · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Trintellix · UBRELVY · VERQUVO · VIVITROL · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · YUPELRI · ZEPBOUND
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a family medicine specialist in New Castle?
Compare family medicine physicians in the New Castle area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians in nearby ZIP areas
348
County median income
$60,779
Nearest hospital to ZIP centroid (approximate)
UPMC JAMESON
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Malvar is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Malvar experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Malvar performed 47 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Malvar receive payments from pharmaceutical companies?
Yes. Dr. Malvar received a total of $14,272 from 49 companies across 692 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Malvar's costs compare to other family medicine physicians in New Castle?
Dr. Malvar's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Malvar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →